|
2025
|
G/S
|
Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucl... |
|
|
G/S
|
Providing medical and scientific research information in the fields of pharmaceuticals and biotec... |
|
|
Invention
|
Compositions and methods of treating muscle atrophy and myotonic dystrophy.
Disclosed herein are... |
|
|
Invention
|
Nucleic acid-polypeptide compositions and methods of inducing exon skipping.
Disclosed herein ar... |
|
|
Invention
|
Nucleic acid-polypeptide compositions and uses thereof.
Disclosed herein are compositions and ph... |
|
2024
|
Invention
|
Compositions and methods for modulating nav1.8.
The present disclosure is related to oligonucleo... |
|
|
Invention
|
Compositions and methods for modulating nav1.8. Nav1.8. |
|
|
G/S
|
Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, an... |
|
|
Invention
|
Antibody-oligonucleotide conjugate compositions and methods of inducing dmd exon 45 skipping.
Di... |
|
|
Invention
|
Antibody-oligonucleotide conjugate compositions and methods of inducing dmd exon 45 skipping. Dis... |
|
|
Invention
|
Compositions and methods of treating facioscapulohumeral muscular dystrophy.
Disclosed herein ar... |
|
|
Invention
|
Anti-transferrin receptor antibody-pmo conjugates for inducing dmd exon 44 skipping. Disclosed he... |
|
|
Invention
|
Compositions and methods of using pln-targeting antibody-oligonucleotide conjugates.
Disclosed h... |
|
|
Invention
|
Compositions and methods of using pln-targeting antibody-oligonucleotide conjugates. PLNPLN targe... |
|
|
Invention
|
Compositions and methods of using prkag2-targeting antibody-oligonucleotide conjugates.
Disclose... |
|
|
Invention
|
Compositions and methods of using prkag2-targeting antibody-oligonucleotide conjugates abstract. ... |
|
|
Invention
|
Conjugate compositions comprising phosphoryl guanidine linkages and uses thereof. Disclosed herei... |
|
|
G/S
|
Biological, medicinal and pharmaceutical preparations, namely, oligonucleotide-conjugate based th... |
|
|
Invention
|
Una amidites and uses thereof.
Disclosed herein are compositions and pharmaceutical formulations... |
|
|
Invention
|
Compositions and methods of treating facioscapulohumeral muscular dystrophy. Disclosed herein are... |
|
2023
|
Invention
|
Anti-transferrin receptor antibodies and uses thereof.
Disclosed herein, in certain embodiments,... |
|
|
G/S
|
Antibodies for medical purposes comprising oligonucleotide-conjugate based therapies, oligonucleo... |
|
|
Invention
|
Compositions and methods of treating muscle dystrophy.
Disclosed herein are polynucleic acid mol... |
|
|
Invention
|
Antibody oligonucleotide conjugate compositions and methods of inducing dmd exon 44 skipping. Dis... |
|
2022
|
Invention
|
Nucleic acid-polypeptide compositions and uses thereof. Disclosed herein are compositions and pha... |
|
|
Invention
|
Compositions and methods of treating muscle atrophy and myotonic dystrophy. Disclosed herein are ... |
|
|
Invention
|
Compositions and methods of treating muscle dystrophy. Disclosed herein are polynucleic acid mole... |
|
|
G/S
|
oligonucleotide-conjugate based therapies; oligonucleotide-antibody conjugate based therapies; ol... |
|
|
Invention
|
Nucleic acid-polypeptide compositions and methods of inducing exon skipping. Disclosed herein are... |
|
|
Invention
|
Antibody-oligonucleotide conjugate and antibody-peptide-oligonucleotide conjugate compositions an... |
|
|
G/S
|
oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, an... |
|
2021
|
Invention
|
Compositions and methods of treating pompe disease.
Disclosed herein are polynucleic acid molecu... |
|
2020
|
Invention
|
Nucleic acid compositions and methods of multi-exon skipping.
Disclosed herein are oligonucleoti... |
